Clinical review report: Cladribine (Mavenclad) (EMD serono)
The objective of this report is to perform a systematic review of the beneficial and harmful effects of cladribine for the treatment of relapsing-remitting multiple sclerosis
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, October 2018
|
Edition: | Version: Final with Redactions |
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this report is to perform a systematic review of the beneficial and harmful effects of cladribine for the treatment of relapsing-remitting multiple sclerosis |
---|---|
Physical Description: | 1 PDF file (76 pages) illustrations |